Amneal Pharmaceuticals Inc. (AMRX)
NASDAQ · Healthcare
Amneal Pharmaceuticals Inc. Net Income 2016–2025
Amneal Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2016 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Amneal Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was 62.3 M, a 410.50% increase year-over-year.
- Amneal Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was 99.2 M, a 230.36% decrease year-over-year.
- Amneal Pharmaceuticals Inc. annual net income for 2025 was 72.1 M, a 161.65% decrease from 2024.
- Amneal Pharmaceuticals Inc. annual net income for 2024 was -116.9 M, a 39.16% increase from 2023.
- Amneal Pharmaceuticals Inc. annual net income for 2023 was -84.0 M, a 68.96% decrease from 2022.
- Amneal Pharmaceuticals Inc. annual net income for 2022 was -270.6 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amneal Pharmaceuticals Inc. Net Income — FAQ
Amneal Pharmaceuticals Inc. (AMRX) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Amneal Pharmaceuticals Inc.'s net income?
Amneal Pharmaceuticals Inc. (AMRX) reported net income of $72M for fiscal 2025.
Where can I see AMRX's net income history?
The chart and table above show Amneal Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.